Photo from Tom Powles/Twitter
Mar 17, 2024, 19:51
Tom Powles: New ESMO’s guidlines for advanced bladder cancer Annals of Oncology – Enforumab Vedotin and pembrolizumab is the new standard of care
Tom Powles, Director of Barts Cancer Center, shared a post on X:
“New ESMO’s guidelines for advanced bladder cancer Annals of Oncology. Enforumab Vedotin and pembrolizumab is the new standard of care. Platinum therapy is now 2nd line and eligibility less relevant.”
View the article.
Source: Tom Powles/X
Jul 1, 2024, 03:08